tiprankstipranks
Novavax (NVAX)
:NVAX
US Market

Novavax (NVAX) Financial Statements

Compare
9,786 Followers

Novavax Financial Overview

Novavax's market cap is currently $1.27B. The company's EPS TTM is $-1.323; its P/E ratio is ―; Novavax is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 682.16M$ 556.38M$ 1.60B$ 1.15B$ 475.60M
Gross Profit$ 479.42M$ 212.61M$ 696.31M$ 1.13B$ -271.43M
Operating Income$ -248.93M$ -566.51M$ -644.74M$ -1.69B$ -416.72M
EBITDA$ -248.93M$ -487.39M$ -604.71M$ -1.68B$ -398.23M
Net Income$ -187.50M$ -545.06M$ -657.94M$ -1.74B$ -427.50M
Balance Sheet
Cash & Short-Term Investments$ 923.12M$ 568.50M$ 1.34B$ 1.52B$ 711.05M
Total Assets$ 1.56B$ 1.80B$ 2.26B$ 2.58B$ 1.58B
Total Debt$ 230.42M$ 229.08M$ 549.78M$ 453.99M$ 322.04M
Net Debt$ -299.81M$ -339.42M$ -787.10M$ -1.06B$ -231.36M
Total Liabilities$ 2.18B$ 2.51B$ 2.89B$ 2.93B$ 955.27M
Stockholders' Equity$ -623.84M$ -716.93M$ -634.08M$ -351.67M$ 627.21M
Cash Flow
Free Cash Flow$ -100.32M$ -772.77M$ -508.92M$ 265.46M$ -97.16M
Operating Cash Flow$ -87.26M$ -713.97M$ -415.94M$ 322.95M$ -42.54M
Investing Cash Flow$ -204.04M$ -58.81M$ -92.98M$ 100.15M$ -377.78M
Financing Cash Flow$ 260.58M$ 4.47M$ 324.99M$ 461.71M$ 984.76M
Currency in USD

Novavax Earnings and Revenue History

Novavax Debt to Assets

Novavax Cash Flow

Novavax Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis